ES2085986T3 - Purificacion de interleuquina-4 humana secretada a partir de un mutante de escherichia coli. - Google Patents

Purificacion de interleuquina-4 humana secretada a partir de un mutante de escherichia coli.

Info

Publication number
ES2085986T3
ES2085986T3 ES91903451T ES91903451T ES2085986T3 ES 2085986 T3 ES2085986 T3 ES 2085986T3 ES 91903451 T ES91903451 T ES 91903451T ES 91903451 T ES91903451 T ES 91903451T ES 2085986 T3 ES2085986 T3 ES 2085986T3
Authority
ES
Spain
Prior art keywords
sodium chloride
mutant
interleukin
purification
escherichia coli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91903451T
Other languages
English (en)
Inventor
John Chu-Tay Tang
David Naveh
T L Nagabhushan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2085986T3 publication Critical patent/ES2085986T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5406IL-4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE PURIFICA INTERLEUCINA RETADO SOMETIENDO DICHA SOLUCION A CROMATOGRAFIA SELECTIVA EN UNA COLUMNA DE AGAROSA QUELANTE DE ZINC A 7.2 PH EN UN REGULADOR QUE CONTIENE UNA ALTA CONCENTRACION DE CLORURO DE SODIO, POR EJEMPLO 1 MOL DE CLORURO DE SODIO, CON LAVADO PREVIO CON UN REGULADOR DE FOSFATO A 7,2 PH QUE CONTIENE 1 MOL DE CLORURO DE SODIO Y POSTERIORMENTE CON UN REGULADOR QUE CONTIENE 10% GLICEROL Y QUE ELUYE A 5,0 PH. LA SOLUCION DE INTERLEUCINA NA RECOMBINANTE ACTIVA PURIFICADA RESULTANTE SE TRATA POSTERIORMENTE MEDIANTE CROMATOGRAFIA DE INTERCAMBIO CATIONICO, CONCENTRACION MEDIANTE DIAFILTRACION HASTA 20 MG/L Y CROMATOGRAFIA DE GEL EXCLUSION DE TAMAÑO UTILIZANDO UN REGULADOR DE NITRATO A 4,5 PH.
ES91903451T 1990-05-31 1991-01-04 Purificacion de interleuquina-4 humana secretada a partir de un mutante de escherichia coli. Expired - Lifetime ES2085986T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/531,270 US5077388A (en) 1990-05-31 1990-05-31 Purification of human interleukin-4 from a secreted escherichia coli mutant

Publications (1)

Publication Number Publication Date
ES2085986T3 true ES2085986T3 (es) 1996-06-16

Family

ID=24116964

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91903451T Expired - Lifetime ES2085986T3 (es) 1990-05-31 1991-01-04 Purificacion de interleuquina-4 humana secretada a partir de un mutante de escherichia coli.

Country Status (16)

Country Link
US (1) US5077388A (es)
EP (1) EP0537148B1 (es)
JP (1) JP2573767B2 (es)
AT (1) ATE136552T1 (es)
AU (1) AU659993B2 (es)
CA (1) CA2084186C (es)
DE (1) DE69118696T2 (es)
DK (1) DK0537148T3 (es)
ES (1) ES2085986T3 (es)
GR (1) GR3019705T3 (es)
IE (1) IE73668B1 (es)
IL (1) IL96880A0 (es)
MY (1) MY130013A (es)
NZ (1) NZ236699A (es)
WO (1) WO1991018919A1 (es)
ZA (1) ZA9193B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100191223B1 (ko) * 1989-07-28 1999-06-15 둘락 노먼 씨. 인터루킨-4의 정제방법 및 이를 함유하는 약제학적 조성물
US5840851A (en) * 1993-07-23 1998-11-24 Plomer; J. Jeffrey Purification of hemoglobin
KR0141651B1 (ko) * 1994-09-07 1998-06-15 강재헌 금속이온 친화성 크로마토그라피를 이용한 히루딘의 정제방법
AU8671798A (en) * 1997-07-30 1999-02-22 Betagene, Inc. Methods and compositions relating to no-mediated cytotoxicity
US6171856B1 (en) 1997-07-30 2001-01-09 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
EP3088412B1 (en) 2001-03-09 2021-05-05 Chugai Seiyaku Kabushiki Kaisha Protein purification method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80678A (en) * 1985-11-19 1999-05-09 Schering Biotech Corp Human interleukin-4
EP0449949A1 (en) * 1988-12-21 1991-10-09 Schering Corporation Use of interleukin-4 for lowering blood-cholesterol levels
KR100191223B1 (ko) * 1989-07-28 1999-06-15 둘락 노먼 씨. 인터루킨-4의 정제방법 및 이를 함유하는 약제학적 조성물

Also Published As

Publication number Publication date
ZA9193B (en) 1991-09-25
MY130013A (en) 2007-05-31
WO1991018919A1 (en) 1991-12-12
JPH05505934A (ja) 1993-09-02
CA2084186A1 (en) 1991-12-01
ATE136552T1 (de) 1996-04-15
IL96880A0 (en) 1992-03-29
US5077388A (en) 1991-12-31
IE910027A1 (en) 1991-12-04
JP2573767B2 (ja) 1997-01-22
DE69118696D1 (de) 1996-05-15
NZ236699A (en) 1992-08-26
EP0537148B1 (en) 1996-04-10
CA2084186C (en) 1999-12-14
DE69118696T2 (de) 1996-08-29
DK0537148T3 (da) 1996-05-06
GR3019705T3 (en) 1996-07-31
EP0537148A1 (en) 1993-04-21
AU659993B2 (en) 1995-06-08
AU7222091A (en) 1991-12-31
IE73668B1 (en) 1997-07-02

Similar Documents

Publication Publication Date Title
AU569129B2 (en) Factor viii:c purification
MY103892A (en) Interleukin-2 of high purity production and use
BE892846A (fr) Procede de purification de substance physiologiquement active a activite antitumorale, et substance ainsi obtenue
ES2085986T3 (es) Purificacion de interleuquina-4 humana secretada a partir de un mutante de escherichia coli.
ES8200560A1 (es) Un procedimiento para producir interferon de fibroblasto hu-mano
DE69027995D1 (de) Reinigungsverfahren von transformierendem wachstumsfaktor (tgf)
JPS6344883A (ja) 新規なヒアルロニダ−ゼsd−678およびその製造法
GB2099008B (en) Enzymatic process for the treatment of xanthan gums to improve the filtrability of their aqueous solutions
Behal et al. Arylamidase of Neisseria catarrhalis
Yoshimoto et al. Affinity chromatographic purification of human lysozyme, with special reference to human leukemia lysozyme
AU1239495A (en) An electrophoretic method to assess human cerebrospinal fluid
FR2583751B1 (fr) Nouveaux antibacteriens contenant des derives des acides oxo-4-pyridine carboxyliques et leur procede de preparation
JPH06256399A (ja) ヒト・インターロイキン11の精製法
JPS5599191A (en) Purification of kallikrein in human urine
Yamamoto et al. Purification of fish gastric hyaluronidase
ATE133421T1 (de) Verfahren zur herstellung von rekombinantem humaninterferon-beta in reiner form
RU96102282A (ru) Способ терапии поллиноза
DK163582A (da) Fremgangsmaade til rensning af et fysiologisk aktivt stof med antitumorvirkning
JPS57140726A (en) Purification of physiologically active substance having carcinostatic action
Varghese et al. Hemolysin of Myxococcus fulvus NK 35: I. Production and Isolation
SU1538513A1 (ru) Способ выделения соматотропина человека
IIMORI et al. Serological Studies on Alpha-Olefin Sulf onate-Protein Complexes
KR920012436A (ko) 인간 인슐린 유사 성장인자-i의 정제 방법
JPS61181395A (ja) マウスインタ−フエロンの精製法
JPS5639780A (en) Purification of glutathioneperoxidase

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 537148

Country of ref document: ES